In addition, elevated serum levels of PKM2 have been observed in patients with various forms of cancer [384,385,386], and recent research has revealed that PKM2 serum levels may possess diagnostic potential as a biomarker for various diseases including lung cancer [387] and inflammatory bowel disease (IBD) [388]. Here, PKM is linked to lung carcinoma.